Inventor · disambiguated record
John A. Lowe, Iii
Also filed as: LOWE II JOHN A · LOWE III JOHN · LOWE III JOHN A · LOWE III JOHN ADAMS
85 granted patents·31 pending applications·1,368 citations·filing 1986–2024
99Inventor score
Top patents by PatentIndex Score
116 records- 0199US4831031AAryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activityPFIZER·Filed 1988·Granted May 16, 1989·307 cites·9 claims
- 0298US9512134B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Dec 6, 2016·35 cites·34 claims
- 0397US11077094B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2019·Granted Aug 3, 2021·7 cites·2 claims
- 0497US10052308B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2016·Granted Aug 21, 2018·19 cites·9 claims
- 0597US9951069B1Bicyclic inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2018·Granted Apr 24, 2018·13 cites·2 claims
- 0697US9579304B2Spiro-lactam NMDA receptor modulators and uses thereofAptinyx Incorporated·Filed 2016·Granted Feb 28, 2017·26 cites·7 claims
- 0797US9504670B2Spiro-lactam NMDA receptor modulators and uses thereofAptinyx Incorporated·Filed 2015·Granted Nov 29, 2016·28 cites·8 claims
- 0897US4880810AQuinazolinediones and pyridopyrimidinedionesPFIZER·Filed 1989·Granted Nov 14, 1989·73 cites·7 claims
- 0996US11225479B2Bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Granted Jan 18, 2022·3 cites·5 claims
- 1096US10441572B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2018·Granted Oct 15, 2019·11 cites·2 claims
- 1196US10441571B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2018·Granted Oct 15, 2019·12 cites·2 claims
- 1296US9828384B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Nov 28, 2017·24 cites·63 claims
- 1395US5162339AQuinuclidine therapeutic agentsPFIZER·Filed 1989·Granted Nov 10, 1992·109 cites·48 claims
- 1494US10793567B2Bicyclic inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2018·Granted Oct 6, 2020·7 cites·16 claims
- 1594US10696673B2Bicyclic inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·5 cites·3 claims
- 1694US9758525B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Sep 12, 2017·23 cites·45 claims
- 1794US9738650B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Aug 22, 2017·22 cites·37 claims
- 1893US10919902B2Hetero-halo inhibitors of histone deacetylaseALKERMES INC·Filed 2019·Granted Feb 16, 2021·4 cites·1 claims
- 1993US9708335B2Spiro-lactam NMDA receptor modulators and uses thereofNAUREX INC·Filed 2014·Granted Jul 18, 2017·22 cites·62 claims
- 2093US8969337B2Prodrugs of secondary amine compoundsALKERMES PHARMA IRELAND LTD·Filed 2012·Granted Mar 3, 2015·16 cites·13 claims
- 2192US11286256B2Bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Granted Mar 29, 2022·2 cites·2 claims
- 2292US10519149B2Bicyclic inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·3 claims
- 2392US10421756B2Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2016·Granted Sep 24, 2019·9 cites·13 claims
- 2492US10273239B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Apr 30, 2019·10 cites·20 claims
- 2592US10253032B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Apr 9, 2019·10 cites·20 claims
- 2692US4883795APiperazinyl-heterocyclic compoundsPFIZER·Filed 1989·Granted Nov 28, 1989·34 cites·16 claims
- 2791US9801879B2Pyridazine derivatives, compositions and methods for treating cognitive impairmentAGENEBIO INC·Filed 2015·Granted Oct 31, 2017·10 cites·13 claims
- 2891US6566550B2Substituted aromatic ethers as inhibitors of glycine transportPFIZER·Filed 2002·Granted May 20, 2003·23 cites·10 claims
- 2990US2025186392A1Spiro-lactam nmda receptor modulators and uses thereofTENACIA BIOTECHNOLOGY HONG KONG CO LTD·Filed 2024·Application pending·0 cites
- 3089US8124639B2Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitorsMCHARDY STANTON F·Filed 2010·Granted Feb 28, 2012·13 cites·3 claims
- 3188US11225475B2Substituted pyridines as inhibitors of histone deacetylaseALKERMES INC·Filed 2018·Granted Jan 18, 2022·3 cites·16 claims
- 3288US10316041B2Spiro-lactam NMDA receptor modulators and uses thereofAPYTINYX INC·Filed 2017·Granted Jun 11, 2019·10 cites·20 claims
- 3388US4891375AArylpiperazinyl-alkylene-phenyl-heterocyclic compoundsPFIZER·Filed 1988·Granted Jan 2, 1990·25 cites·13 claims
- 3487US9145372B2Pyridazine derivatives, compositions and methods for treating cognitive impairmentLOWE III JOHN A·Filed 2011·Granted Sep 29, 2015·15 cites·61 claims
- 3587US5373003A1-azabicyclo[3.2.2]nonan-3-amine derivativesPFIZER·Filed 1992·Granted Dec 13, 1994·61 cites·11 claims
- 3683US5484917ASubstituted tetrahydrobenzazepinonesPFIZER·Filed 1993·Granted Jan 16, 1996·21 cites·4 claims
- 3779US12167998B2Spiro-lactam NMDA receptor modulators and uses thereofTENACIA BIOTECHNOLOGY HONG KONG CO LTD·Filed 2021·Granted Dec 17, 2024·0 cites·2 claims
- 3879US11987580B2Bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2021·Granted May 21, 2024·0 cites·17 claims
- 3977US7012078B22-aminopyridines containing fused ring substituentsPFIZER·Filed 2002·Granted Mar 14, 2006·6 cites·4 claims
- 4077US5037834AHeterocycylic-substituted quinoline-carboxylic acidsPFIZER·Filed 1989·Granted Aug 6, 1991·23 cites·7 claims
- 4176US7473787B2Bicyclic [3.1.0] derivatives as glycine transporter inhibitorsPFIZER·Filed 2004·Granted Jan 6, 2009·9 cites·4 claims
- 4276US6372768B22-aminopyridines containing fused ring substituentsPFIZER·Filed 2001·Granted Apr 16, 2002·8 cites·3 claims
- 4375US6465491B26-phenylpyridyl-2-amine derivativesPFIZER·Filed 2001·Granted Oct 15, 2002·7 cites·6 claims
- 4474US7101885B2Piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactamsPFIZER·Filed 2004·Granted Sep 5, 2006·6 cites·5 claims
- 4573US11858939B2Hetero-halo inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Granted Jan 2, 2024·0 cites·1 claims
- 4673US6710071B2Difluoromethylene aromatic ethers as inhibitors of glycine transportPFIZER·Filed 2002·Granted Mar 23, 2004·6 cites·17 claims
- 4773US6211208B12-aminopyridines containing fused ring substituentsPFIZER·Filed 2000·Granted Apr 3, 2001·5 cites·19 claims
- 4872US11912702B2Substituted pyridines as inhibitors of histone deacetylaseALKERMES INC·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 4972US10774064B2Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2017·Granted Sep 15, 2020·1 cites·17 claims
- 5072US7101881B2TetrahydroquinolinesPFIZER·Filed 2004·Granted Sep 5, 2006·5 cites·4 claims
Showing the top 50 of 116 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John A. Lowe, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →